FDA Approves OXYCODONE HYDROCHLORIDE — Novel Laboratories, Inc.

The FDA has granted final approval to Novel Laboratories, Inc. for its Abbreviated New Drug Application (ANDA) involving oxycodone hydrochloride, positioning the company to broaden its footprint in the opioid pain management market amidst ongoing regulatory scrutiny.